How Long Does Vascepa's Financial Assistance Process Take?
Vascepa (icosapent ethyl) offers patient assistance through the Vascepa Savings Card and the Vascepa Patient Assistance Program (PAP), both managed by Amarin Pharma. The Savings Card provides instant copay reduction for commercially insured patients upon online enrollment or app download, often activating within minutes at the pharmacy.[1] Full PAP approval for uninsured or underinsured patients typically takes 2-5 business days after submitting an application with proof of income, insurance status, and prescription details via fax, mail, or online portal.[2]
What Steps Are Involved in Applying?
Patients start by visiting the official Vascepa support site (vascepasupport.com) to check eligibility. Savings Card requires basic info like email and pharmacy details—no income verification needed. PAP demands more: a healthcare provider completes part of the form, patients provide financial docs (e.g., tax returns or pay stubs), then submit. Processing starts once received; status updates come via email or phone.[1][2]
How Long Until You Receive the Medication?
Approved Savings Card users get immediate pharmacy reimbursement. PAP approvals ship medication within 7-10 business days of approval, with up to a 90-day supply renewed every 12 months if eligible. Delays occur if docs are incomplete, adding 2-3 days for resubmission.[2]
Common Reasons for Delays and How to Avoid Them
Incomplete applications or missing income proof cause most holdups, extending timelines to 7-10 business days. Patients report faster processing (under 3 days) when providers pre-fill forms digitally. Call 1-833-VASCEPA for status checks.[1]
Alternatives If Vascepa Assistance Is Too Slow
- Competitor programs: Lovaza (similar indication) has a PAP with 3-7 day approvals via AbbVie's myAbbVie Assist.[3]
- General options: NeedyMeds or RxAssist list hypertriglyceridemia copay cards with 1-3 day processing.
- Generic ethyl esters: Cheaper off-patent versions may bypass assistance needs.
No patents block Vascepa generics until at least 2031 (U.S. Patent 8,663,699 expiry).[4]
[1]: vascepasupport.com/savings-card
[2]: vascepasupport.com/patient-assistance
[3]: lovaza.com/savings-support
[4]: DrugPatentWatch.com - Vascepa